Medical expenditures for fragility hip fracture in Japan: a study using the nationwide health insurance claims database

[1] Williamson S(2017)Costs of fragility hip fractures globally: a systematic review and meta-regression analysis Osteoporos Int 28 2791-2800

[2] Landeiro F(2004)Association of hospital resource use with comorbidity status and patient age among hip fracture patients in Japan Health Policy 69 179-187

[3] McConnell T(2008)E-PASS for predicting postoperative risk with hip fracture: a multicenter study Clin Orthop Relat Res 466 2833-2841

[4] Fulford-Smith L(2009)Comparison of outcomes and costs after hip fracture surgery in three hospitals that have different care systems in Japan Health Policy 91 204-210

[5] Javaid MK(2018)Estimated expenditures for hip fractures using merged healthcare insurance data for individuals aged≥ 75 years and long-term care insurance claims data in Japan Arch Osteoporos 13 37-518

[6] Judge A(2018)Treatment costs and cost drivers among osteoporotic fracture patients in Japan: a retrospective database analysis Arch Osteoporos 13 45-38

[7] Leal J(2019)Variation in fracture risk by season and weather: a comprehensive analysis across age and fracture site using a national database of health insurance claims in Japan Bone 120 512-785

[8] Ishizaki T(2019)Decreased risk of fragility fractures associated with statin use in the older Japanese population: a nationwide case–crossover study BPB Rep 2 35-347

[9] Imanaka Y(2019)Fragility fractures in older people in Japan based on the national health insurance claims database Biol Pharm Bull 42 778-1197

[10] Oh E(2020)Central nervous system agent classes and fragility fracture risk among elderly Japanese individuals in a nationwide case-crossover design study Biol Pharm Bull 43 340-983

[1] Williamson S(2017)Costs of fragility hip fractures globally: a systematic review and meta-regression analysis Osteoporos Int 28 2791-2800

[2] Landeiro F(2004)Association of hospital resource use with comorbidity status and patient age among hip fracture patients in Japan Health Policy 69 179-187

[3] McConnell T(2008)E-PASS for predicting postoperative risk with hip fracture: a multicenter study Clin Orthop Relat Res 466 2833-2841

[4] Fulford-Smith L(2009)Comparison of outcomes and costs after hip fracture surgery in three hospitals that have different care systems in Japan Health Policy 91 204-210

[5] Javaid MK(2018)Estimated expenditures for hip fractures using merged healthcare insurance data for individuals aged≥ 75 years and long-term care insurance claims data in Japan Arch Osteoporos 13 37-518

[6] Judge A(2018)Treatment costs and cost drivers among osteoporotic fracture patients in Japan: a retrospective database analysis Arch Osteoporos 13 45-38

[7] Leal J(2019)Variation in fracture risk by season and weather: a comprehensive analysis across age and fracture site using a national database of health insurance claims in Japan Bone 120 512-785

[8] Ishizaki T(2019)Decreased risk of fragility fractures associated with statin use in the older Japanese population: a nationwide case–crossover study BPB Rep 2 35-347

[9] Imanaka Y(2019)Fragility fractures in older people in Japan based on the national health insurance claims database Biol Pharm Bull 42 778-1197

[10] Oh E(2020)Central nervous system agent classes and fragility fracture risk among elderly Japanese individuals in a nationwide case-crossover design study Biol Pharm Bull 43 340-983